VIELA BIO, INC. Proceeds from Stock Options Exercised
VIELA BIO, INC. reported Proceeds from Stock Options Exercised of $1.34 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2021-03-01
- VIELA BIO, INC. proceeds from stock options exercised for the quarter ending 2020-12-31 was $261.00K, a 5.24% increase year-over-year.
- VIELA BIO, INC. proceeds from stock options exercised for the quarter ending 2020-09-30 was $535.00K, a 28.30% increase year-over-year.
- VIELA BIO, INC. proceeds from stock options exercised for the quarter ending 2020-06-30 was $447.00K.
- VIELA BIO, INC. proceeds from stock options exercised for the quarter ending 2020-03-31 was $102.00K.
- VIELA BIO, INC. proceeds from stock options exercised for fiscal 2020 was $1.34M, a 11.57% decline from fiscal 2019.
- VIELA BIO, INC. proceeds from stock options exercised for fiscal 2019 was $1.52M.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2020-12-31 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $796.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.24M derived: sum of 3 quarters · filed 2021-03-01 | $1.34M 10-K · filed 2021-03-01 |
| 2020-09-30 | $535.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $982.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.08M 10-Q · filed 2020-11-10 | $1.33M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | $447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $549.00K 10-Q · filed 2020-08-12 | $797.00K derived: sum of 3 quarters · filed 2021-03-01 | $1.21M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | $102.00K 10-Q · filed 2020-05-13 | $350.00K derived: sum of 2 quarters · filed 2021-03-01 | $767.00K derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-12-31 | $248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $665.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.52M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $417.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.27M 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $856.00K 10-Q · filed 2020-08-12 |